According to Gan Li Pharmaceutical's announcement, 7 directors and senior managers, including Chen Wei and Song Weiqiang, plan to reduce their holdings by no more than 120,000 shares through centralized bidding transactions, that is, no more than 23.077% of the company's shares held by them, not more than 0.02% of the company's total share capital. The reason for the reduction is to repay personal debts. There is uncertainty about the implementation of this holdings reduction plan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.